PG

Paul Grayson

Chief Executive Officer

Radionetics Oncology

Therapeutic Areas

Radionetics Oncology Pipeline

DrugIndicationPhase
Undisclosed GPCR-targeting programsBroad range of cancers including breast cancer, lung cancerPreclinical